Preemptive inotuzumab ozogamicin eradicated measurable residual disease in Ph‐negative acute lymphoblastic leukemia relapsed post CD19 CART therapy
Article in Clinical Case Reports (December 2023)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Article in Clinical Case Reports (December 2023)
Article in Chinese Journal of Hematology (August 2022)
Article in Hematology (April 2022)